ArticleFrontiers in pharmacology2020

Liquiritin Alleviates Pain Through Inhibiting CXCL1/CXCR2 Signaling Pathway in Bone Cancer Pain Rat.

Huadong Ni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.